Ignite Creation Date:
2025-12-25 @ 12:41 AM
Ignite Modification Date:
2025-12-25 @ 10:52 PM
Study NCT ID:
NCT01421667
Status:
COMPLETED
Last Update Posted:
2016-11-28
First Post:
2011-08-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Sponsor:
Seagen Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-08
Start Date Type:
None
Primary Completion Date:
2015-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-06
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-19
First Submit QC Date:
None
Study First Post Date:
2011-08-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-06-21
Results First Submit QC Date:
None
Results First Post Date:
2016-10-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-14
Last Update Post Date:
2016-11-28
Last Update Post Date Type:
ESTIMATED